POLYSERP™ offers freeze-dried unrefrigerated snake antivenoms designed specifically for the treatment of envenomation casualties in operational and austere medicine environments. POLYSERP™ antivenoms come in two broad-spectrum, regionally-specific formulations that are indicated for the treatment of neurotoxic, hemotoxic, and cytotoxic snake envenomations by all of the critical threat species in a given area without the need to identify the snake.
Safe For Field Use
Traditional concerns with antivenoms arose from the high risk of serious reactions such as anaphylaxis, which occurred in as high as 75% of patients treated in some studies on older products. The rate of serious reactions to POLYSERP™ has been reduced to ? 1% thanks to a patented multi-step process of fragmentation, purification, and lyophilization resulting in a product that is free of preservatives and safe enough to administer by direct IV push in a low resource environment.
Unrefrigerated, Freeze-Dried, Field Stable
POLYSERP™ has been designed from the ground up to meet the needs of austere medical providers. Each vial contains a minimum of 500 LD50 neutralization potency against the most dangerous regional snakes. The increased potency allows field providers to treat severe envenomations at the point of injury, reducing the amount of space and weight, while adding an invaluable medical capability.
No Cold-Chain
Snakes are abundant in warm climates due to their cold-blooded physiology, but most antivenoms require constant refrigeration. POLYSERP™ is a next generation product that can be carried in a backpack for 6 months at temperatures exceeding 100º F without any loss of potency, making it the first product that is specifically designed for use in the environments where snakes are most common and disaster is most likely to strike.
US GOVERNMENT SALES
POLYSERP™
228 Park Ave. S. Suite 29413
New York, New York 10003-1502
sales@polyserptherapeutics.com
United States Patent 10,538,577
Learn more at www.polyserptherapeutics.com
Purchase available with physician-sponsor. Please contact sales@polyserptherapeutics.com for ordering information.
Very interesting! Could be a real lifesaver.
A interesting development in toxinocolgy and antivenin technology. The problems with snake identification, antivenin administration and cold chain have been identified and addressed .
I would like to see a similar product here in Australia for our own toxic elapids .